Overview
Erin Hofstatter is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Hofstatter is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.
Her clinical research consists of co-authoring 44 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Yale University
Lajos Pusztai is an Oncologist in New Haven, Connecticut. Dr. Pusztai is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.
Hartford Hospital
Daniel Morganstern is a Hematologist Oncology specialist and a Hematologist in Manchester, Connecticut. Dr. Morganstern is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.
Julie Gold is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Hofstatter isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Hofstatter isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Hofstatter isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Hofstatter isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- BRCA Positive Breast CancerDr. Hofstatter isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Hofstatter isExperienced. Learn about Breast Cancer in Men.
- DICER1 SyndromeDr. Hofstatter isExperienced. Learn about DICER1 Syndrome.
- HER2 Negative Breast CancerDr. Hofstatter isExperienced. Learn about HER2 Negative Breast Cancer.
- Intraductal PapillomaDr. Hofstatter isExperienced. Learn about Intraductal Papilloma.
- Li-Fraumeni SyndromeDr. Hofstatter isExperienced. Learn about Li-Fraumeni Syndrome.